Health & Fitness
Health and Fitness
Health and Fitness 
Mon, April 18, 2011
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - Market Wire
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - WOPRAI
[ Mon, Apr 18th 2011
] - Market Wire
CHMP recomienda actualizar la etiqueta de TYSABRI con estatus de anticuerpo anti-JCV como tercer factor para estratificar los r
WESTON, Massachussets & DUBLIN--([ BUSINESS WIRE ])--[ Biogen Idec ] (NASDAQ: BIIB) y [ Elan Corporation ], plc (NYSE: ELN) han comunicado que el Comit© de Medicamentos de Uso Humano (CHMP en sus siglas en ingl©s) ha emitido una opinin positiva para la inclusin de un factor adicional de riesgo, estatus de anticuerpos anti-JCV, en la etiqueta del producto de [ TYSABRI ]® (natalizumab) en la Unin Europea. El CHMP tambi©n ha emitido una opinin positiva para la renovacin de cinco aos de la autorizacin de comercializacin de TYSABRI.
El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.